Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy

  • Cell Rep Med. 2025 Sep 16;6(9):102324. doi: 10.1016/j.xcrm.2025.102324.
Freya Q Zhang  1 Jiacheng Li  1 Rukang Zhang  1 Jiayi Tu  1 Zhicheng Xie  1 Takemasa Tsuji  2 Hardik Shah  1 Matthew O Ross  3 Ruitu Lyu  3 Junko Matsuzaki  2 Anna Tabor  2 Kelly Xue  1 Fatima Choudhry  4 Chunzhao Yin  1 Hamed R Youshanlouei  1 Syed Shah  1 Michael W Drazer  1 Yu-Ying He  1 B Marc Bissonnette  1 Yuancheng Li  5 Hui Mao  5 Jun Huang  6 Lei Dong  7 Rui Su  8 Chuan He  3 Kunle Odunsi  2 Jing Chen  9 Hao Fan  10
Affiliations
  • 1. Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
  • 2. Department of Obstetrics & Gynecology, The University of Chicago, Chicago, IL 60637, USA.
  • 3. Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA.
  • 4. Health Science, DePaul University, Chicago, IL 60614, USA.
  • 5. Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • 6. Pritzker School of Molecular Engineering, The University of Chicago, Chicago, IL 60637, USA.
  • 7. University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • 8. Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
  • 9. Department of Medicine, The University of Chicago, Chicago, IL 60637, USA. Electronic address: [email protected].
  • 10. Department of Medicine, The University of Chicago, Chicago, IL 60637, USA. Electronic address: [email protected].
Abstract

The detailed mechanisms underlying the regulatory significance of dietary components in modulating anti-tumor immunity remain largely unknown. Here, we apply a co-culture-based screening approach using a blood nutrient compound library and identify zeaxanthin (ZEA), a dietary carotenoid pigment found in many fruits and vegetables and known for its role in eye health, as an immunomodulator that enhances the cytotoxicity of CD8+ T cells against tumor cells. Oral supplementation with ZEA, but not its structural isomer lutein (LUT), enhances anti-tumor immunity in vivo. Integrated multi-omics mechanistic studies reveal that ZEA promotes T cell receptor (TCR) stimulation on the CD8+ T cell surface, leading to improved intracellular TCR signaling for effector T cell function. Hence, ZEA treatment augments the efficacy of anti-PD1 immune checkpoint inhibitor in vivo and the cytotoxicity of human TCR gene-engineered CD8+ T cells in vitro. Our findings uncover a previously unknown immunoregulatory function of ZEA, which has translational potential as a dietary element in bolstering immunotherapy.

Products